Autopsy report · NCT02111551

Phase I Nicotinic Agonist Treatment Trial for Autism

“difficult to find participants and no funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months before it started.
• Ran for about 11 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Colorado, Denver

Sponsor type

University, hospital or other

Conditions

Autism

Interventions

DMXB-A 150 mg; placebo; DMXB-A 75 mg

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis
  “Difficulty finding eligible participants and lack of funding.” (87% match in meaning)
• Quality of Life in Patients With Multiple Myeloma-validation Study
  “Not enough participants and study funding” (75% match in meaning)
• Transcranial Direct Current Stimulation for Freezing of Gait
  “difficult to recruit participants” (72% match in meaning)
• Exparel in Minimally Invasive Cardiac Surgery
  “Lack of available participants that meet criteria” (72% match in meaning)
• In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA
  “Funding withdrawn, no participants recruited” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.